Liu, Chengming
Zheng, Sufei
Lu, Zhiliang
Wang, Zhanyu
Wang, Sihui
Feng, Xiaoli
Wang, Yan
Sun, Nan
Funding for this research was provided by:
Natural Science Foundation of Beijing Municipality (7204291)
National Natural Science Foundation of China (32170923)
Article History
Received: 23 March 2022
Revised: 22 August 2022
Accepted: 14 September 2022
First Online: 21 October 2022
Ethics declarations
: The study protocol was approved by the Ethics Committee of Cancer Hospital and Institution, Chinese Academy of Medical Sciences (Beijing, China), and the approval number was 20/242-2438. All FFPE samples with LUSC were obtained following the provision of informed consent.
: The manuscript is approved by all authors for publication.
: The authors declare no competing interests.